| Autor: |
Sarah Cocco, K French, V Siebring, Christopher Vinden, Brian Yan, Zaid Hindi, A Wong, Leonardo Guizzetti, S Al-obaid, D Chakraborti, Michael Sey, J C Gregor, M Brahmania, Anouar Teriaky, M Blier, Cassandra McDonald, Aze Wilson, Nitin Khanna, O Siddiqi, Vipul Jairath, b makandey, Muriel Brackstone, M ALasseger |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
J Can Assoc Gastroenterol |
| Popis: |
Background The use of propofol during colonoscopy has gained increased popularity due to deeper anesthesia compared to conscious sedation. Prior studies examining the use of propofol sedation during colonoscopy have primarily focused on anesthesia outcomes. Whether propofol sedation is associated with improvements in colonoscopy outcomes is uncertain. Aims The primary outcome was adenoma detection rate (ADR). Secondary outcomes were the detection of any adenoma (conventional adenoma, sessile serrated polyp, and traditional serrated adenoma), sessile serrated polyp detection rate, polyp detection rate, cecal intubation rate, and perforation rate. Methods The Southwest Ontario Colonoscopy cohort consists of all patients who underwent colonoscopy between April 2017 and Oct 2018 at 21 hospitals serving a large geographic area in Southwest Ontario. Procedures performed in patients less than 18 years of age or by endoscopist who perform Results A total of 46,634 colonoscopies were performed by 75 physicians (37.5% by gastroenterologists, 60% by general surgeons, 2.5% others) of which 16,408 (35.2%) received propofol and 30,226 (64.8%) received conscious sedation (e.g. combination of a benzodiazepine and a narcotic). Patients who received propofol were likely to have a screening indication (49.2% vs 45.5%, p Conclusions The use of propofol sedation does not improve colonoscopy quality metrics. Funding Agencies None |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
